RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock
$0,97
Precio · May 20, 2026
Fundamentales a fecha de May 15, 2026
Rango 52S
$0–$4
17% of range
Calificación del Analista
BUY
10 analysts
Precio Objetivo
$8
+677% upside
P/E (TTM)
-3.0
ROE
-169.6%
Margen de Beneficio Neto
-1817.1%
RANI Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.97
Capitalización Bursátil
—
P/E (TTM)
-3.0
BPA (TTM)
$-0.45
Ingresos (TTM)
$2M
Rendimiento div.
—
ROE
-169.6%
Deuda/Capital
0.0
Rango 52S
$0 – $4
RANI Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$2M
2020-12-31
→
2025-12-31
BPA
$-0.45
2021-12-31
→
2025-12-31
Flujo de caja libre
$-19M
2021-12-31
→
2025-12-31
Márgenes
-1817.1%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
RANI
Mediana de Pares
P/E (TTM)
-3.0
22.6
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
RANI
Mediana de Pares
Operating Margin (Margen Operativo)
-2346.0%
—
Net Profit Margin (Margen de Beneficio Neto)
-1817.1%
-6.4%
ROA
-62.3%
-62.6%
ROE
-169.6%
-59.0%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
RANI
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
0.0
0.0
Current Ratio (Ratio corriente)
4.2
2.7
Quick Ratio (Ratio Rápido)
1.6
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
RANI
Mediana de Pares
Revenue YoY (Ingresos interanuales)
58.9%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
-27.7%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
28.7%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
RANI
Mediana de Pares
RANI Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
10 analistas
- Compra fuerte 2 20,0%
- Compra 7 70,0%
- Mantener 1 10,0%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
4 analistas · 2026-05-18
Mediana
$7.00
Media
$7.50
← Por Debajo de Todos los Objetivos
$0.97
Mín
$5.00
Máx
$11.00
Objetivo mediano
$7.00
+624,9%
Objetivo medio
$7.50
+676,7%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.00%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.04 | $-0.05 | 0.01% |
| 31 de diciembre de 2025 | $-0.07 | $-0.07 | -0.00% |
| 30 de septiembre de 2025 | $-0.12 | $-0.13 | 0.01% |
| 30 de junio de 2025 | $-0.18 | $-0.20 | 0.02% |
| 31 de marzo de 2025 | $-0.22 | $-0.21 | -0.01% |
| 31 de diciembre de 2024 | $-0.27 | $-0.25 | -0.02% |
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| RANI | — | -3.0 | 58.9% | -1817.1% | -169.6% | — |
| ASRT | $58M | -1.9 | -5.0% | -25.6% | -32.4% | — |
| NTHI | — | -2.6 | -51.8% | — | — | — |
| TTRX | $116M | -32.8 | — | — | -141.7% | — |
| CGTX | $120M | -4.2 | — | — | -113.7% | — |
| NRXP | — | — | — | — | — | — |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $2M | $1M | $0 | $0 | $3M | $462.0K | |
| R&D Expense | $20M | $27M | $40M | $37M | $26M | $12M | |
| SG&A Expense | $20M | $24M | $26M | $27M | $28M | $5M | |
| Operating Expenses | $40M | $54M | $66M | $63M | $54M | $-17M | |
| Operating Income | $-38M | $-53M | $-66M | $-63M | $-52M | $-17M | |
| Interest Expense | $3M | $5M | $5M | $1M | $466.0K | $124.0K | |
| Interest Income | · | · | · | · | $89.0K | $63.0K | |
| Pretax Income | · | · | $-68M | $-63M | $-53M | $-17M | |
| Income Tax | $0 | $0 | $0 | $70.0K | $41.0K | $35.0K | |
| Net Income | $-30M | $-30M | $-34M | $-31M | $-8M | · | |
| EPS (Basic) | $-0.45 | $-1.05 | $-1.33 | $-1.28 | $-0.43 | · | |
| EPS (Diluted) | $-0.45 | $-1.05 | $-1.33 | $-1.28 | $-0.43 | · | |
| Shares (Basic) | 66,138 | 28,476 | 25,505 | 23,817 | 19,534 | · | |
| Shares (Diluted) | 66,138 | 28,476 | 25,505 | 23,817 | 19,534 | · | |
| EBITDA | $-38M | $-53M | $-66M | $-63M | $-52M | · |
Balance general 23
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $4M | $6M | $27M | $117M | $73M | |
| Short-term Investments | · | · | · | $98M | · | · | |
| Receivables | $2M | $0 | · | · | · | · | |
| Prepaid Expense | $2M | $2M | $2M | $2M | $2M | $167.0K | |
| Current Assets | $53M | $30M | $51M | $101M | $120M | $75M | |
| PP&E (Net) | $736.0K | $2M | $6M | $6M | $5M | $4M | |
| PP&E (Gross) | · | · | $6M | $4M | $3M | $3M | |
| Accum. Depreciation | $6M | $5M | $4M | $3M | $2M | $2M | |
| Other Non-current Assets | $246.0K | $246.0K | $246.0K | $0 | · | · | |
| Total Assets | $59M | $37M | $58M | $108M | $124M | $79M | |
| Accounts Payable | $309.0K | $1M | $648.0K | $1M | $1M | $537.0K | |
| Accrued Liabilities | · | · | · | $2M | $1M | $550.0K | |
| Current Liabilities | $13M | $20M | $8M | $5M | $3M | $5M | |
| Capital Leases | $3M | $4M | $0 | $59.0K | $0 | · | |
| Total Liabilities | $17M | $33M | $32M | $34M | $3M | $8M | |
| Long-term Debt | $0 | $25M | $30M | $30M | · | $4M | |
| Total Debt | $0 | $25M | $29M | $29M | · | · | |
| Common Stock | · | · | · | · | · | $0 | |
| Paid-in Capital | $166M | $105M | $86M | $76M | $56M | $0 | |
| Retained Earnings | $-133M | $-103M | $-73M | $-39M | $-8M | $-114M | |
| AOCI | $1.0K | $5.0K | $-12.0K | $-73.0K | $0 | · | |
| Stockholders' Equity | $33M | $2M | $13M | $37M | $47M | $-113M | |
| Liabilities + Equity | $59M | $37M | $58M | $108M | $124M | $79M |
Flujo de Efectivo 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $900.0K | $1M | $822.0K | $548.0K | $497.0K | · | |
| Stock-based Comp | $12M | $16M | $19M | $16M | $23M | · | |
| Deferred Tax | · | · | · | $0 | $0 | $0 | |
| Operating Cash Flow | $-19M | $-35M | $-51M | $-47M | $-32M | $-15M | |
| CapEx | $88.0K | $268.0K | $1M | $2M | $506.0K | $1M | |
| Investing Cash Flow | $-7M | $20M | $30M | $-72M | $-506.0K | $-1M | |
| Net Debt Issued | $-21M | $-5M | · | · | · | · | |
| Stock Issued | · | · | · | · | $71M | · | |
| Net Stock Activity | · | · | · | · | $71M | · | |
| Financing Cash Flow | $40M | $14M | $233.0K | $29M | $77M | $73M | |
| Net Change in Cash | $15M | $-2M | $-21M | $-90M | $44M | $57M | |
| Taxes Paid | $0 | $0 | $35.0K | $48.0K | $73.0K | · | |
| Free Cash Flow | $-19M | $-36M | $-52M | $-48M | $-33M | · | |
| Levered FCF | · | · | $-58M | $-49M | $-33M | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -2346.0% | -5186.2% | · | · | -1899.1% | · | |
| Net Margin | -1817.1% | -2920.0% | · | · | -306.6% | · | |
| Pretax Margin | · | · | · | · | -1952.4% | · | |
| EBITDA Margin | -2346.0% | -5186.2% | · | · | -1899.1% | · | |
| ROA | -62.3% | -63.5% | -40.9% | -26.3% | -8.2% | · | |
| ROE | -169.6% | -404.1% | -136.6% | -72.6% | 25.3% | · | |
| ROIC | · | · | -156.5% | -96.2% | -108.9% | · |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 4.2 | 1.5 | 6.4 | 21.0 | 45.3 | · | |
| Quick Ratio | 1.6 | 0.2 | 0.7 | 26.1 | 44.5 | · | |
| Debt / Equity | 0.0 | 12.4 | 2.3 | 0.8 | · | · | |
| LT Debt / Equity | 0.0 | 4.8 | 1.9 | 0.8 | · | · | |
| Interest Coverage | -13.3 | -10.6 | -13.0 | -59.2 | -110.7 | · |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · | |
| Receivables Turnover | 1.6 | · | · | · | · | · |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 58.9% | · | · | · | 488.1% | · | |
| Revenue CAGR 3Y | · | -27.7% | · | · | · | · | |
| Revenue CAGR 5Y | 28.7% | · | · | · | · | · |
Valoración (TTM) 4
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $1M | $0 | $0 | $3M | · | |
| Net Income TTM | $-30M | $-30M | $-34M | $-31M | $-8M | · | |
| P/E | -3.0 | -1.3 | -2.5 | -4.6 | -38.0 | · | |
| Earnings Yield | -33.3% | -76.6% | -40.1% | -21.7% | -2.6% | · |
Estado de resultados 14
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $1M | $0 | $0 | $172.0K | $1M | $0 | $0 | $0 | · | · | · | · | · | $0 | $0 | |
| R&D Expense | $5M | $5M | $3M | $6M | $7M | $7M | $6M | $6M | $8M | $8M | $11M | $11M | $10M | $10M | $9M | $10M | |
| SG&A Expense | $5M | $5M | $4M | $5M | $6M | $5M | $6M | $6M | $6M | $6M | $7M | $7M | $7M | $7M | $7M | $6M | |
| Operating Expenses | $10M | $10M | $7M | $11M | $12M | $16M | $12M | $13M | $14M | $13M | $18M | $18M | $17M | $17M | $16M | $16M | |
| Operating Income | $-8M | $-9M | $-7M | $-11M | $-12M | $-15M | $-12M | $-13M | $-14M | $-13M | $-18M | $-18M | $-17M | $-17M | $-16M | $-16M | |
| Interest Expense | $88.0K | $346.0K | $725.0K | $877.0K | $943.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $719.0K | $352.0K | $0 | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-18M | $-19M | $-17M | $-17M | $-16M | $-16M | |
| Income Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $-254.0K | $107.0K | $154.0K | |
| Net Income | $-7M | $-10M | $-5M | $-7M | $-7M | $-9M | $-7M | $-7M | $-7M | $-7M | $-9M | $-9M | $-8M | $-9M | $-8M | $-8M | |
| EPS (Basic) | $-0.04 | $0.07 | $-0.12 | $-0.18 | $-0.22 | $-0.26 | $-0.24 | $-0.26 | $-0.29 | $-0.27 | $-0.36 | $-0.37 | $-0.33 | $-2.21 | $0.33 | $0.31 | |
| EPS (Diluted) | $-0.04 | $0.07 | $-0.12 | $-0.18 | $-0.22 | $-0.26 | $-0.24 | $-0.26 | $-0.29 | $-0.27 | $-0.36 | $-0.37 | $-0.33 | $-2.21 | $0.33 | $0.31 | |
| Shares (Basic) | 179,996,000 | -116,359,862 | 46,444,000 | 36,542,000 | 33,440,000 | -81,165,524 | 28,836,000 | 26,324,000 | 26,034,000 | -76,111,495 | 25,552,000 | 25,345,000 | 25,240,000 | -70,224,183 | 24,468,000 | 24,371,000 | |
| Shares (Diluted) | 179,996,000 | -116,359,862 | 46,444,000 | 36,542,000 | 33,440,000 | -81,165,524 | 28,836,000 | 26,324,000 | 26,034,000 | -76,111,495 | 25,552,000 | 25,345,000 | 25,240,000 | -70,224,183 | 24,468,000 | 24,371,000 | |
| EBITDA | $-8M | · | $-7M | $-11M | $-12M | · | $-12M | $-13M | $-14M | · | $-18M | $-18M | $-17M | · | $-16M | $-16M |
Balance general 21
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $19M | $4M | $10M | $10M | $4M | $4M | $5M | $7M | $6M | $5M | $8M | $19M | $27M | $27M | $97M | |
| Receivables | $2M | $2M | · | · | $600.0K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $2M | $811.0K | $857.0K | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $812.0K | |
| Current Assets | $47M | $53M | $5M | $11M | $18M | $30M | $32M | $32M | $41M | $51M | $63M | $76M | $89M | $101M | $101M | $98M | |
| PP&E (Net) | $601.0K | $736.0K | $922.0K | $1M | $1M | $2M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | · | · | |
| Accum. Depreciation | $6M | $6M | · | · | · | $5M | · | · | · | $4M | · | · | · | $3M | · | · | |
| Other Non-current Assets | $246.0K | $246.0K | $245.0K | $293.0K | $246.0K | $246.0K | $246.0K | $246.0K | $246.0K | $246.0K | · | · | · | $0 | · | · | |
| Total Assets | $52M | $59M | $10M | $17M | $24M | $37M | $44M | $44M | $54M | $58M | $70M | $84M | $96M | $108M | $108M | $104M | |
| Accounts Payable | $858.0K | $309.0K | $2M | $2M | $2M | $1M | $2M | $506.0K | $806.0K | $648.0K | $1M | $1M | $2M | $1M | $2M | $1M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | $3M | |
| Current Liabilities | $14M | $13M | $19M | $21M | $20M | $20M | $20M | $17M | $13M | $8M | $7M | $6M | $5M | $5M | $7M | $5M | |
| Capital Leases | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $0 | $171.0K | $338.0K | $500.0K | $59.0K | $318.0K | $341.0K | |
| Total Liabilities | $16M | $17M | $22M | $26M | $29M | $33M | $38M | $38M | $39M | $32M | $36M | $35M | $35M | $34M | $22M | $6M | |
| Long-term Debt | · | $0 | $14M | $18M | $21M | $25M | $29M | $30M | $30M | $29M | $30M | $30M | $30M | $29M | $15M | · | |
| Total Debt | · | · | $14M | $17M | $21M | · | $28M | $29M | $29M | · | $29M | $29M | $29M | · | $14M | · | |
| Paid-in Capital | $168M | $166M | $114M | $111M | $107M | $105M | $97M | $90M | $88M | $86M | $83M | $81M | $78M | $76M | $72M | $70M | |
| Retained Earnings | $-140M | $-133M | $-122M | $-117M | $-110M | $-103M | $-94M | $-87M | $-80M | $-73M | $-66M | $-57M | $-47M | $-39M | $-30M | $-22M | |
| AOCI | $-8.0K | $1.0K | $3.0K | $3.0K | $2.0K | $5.0K | $8.0K | $-5.0K | $-11.0K | $-12.0K | $-41.0K | $-63.0K | $-10.0K | $-73.0K | $-57.0K | · | |
| Stockholders' Equity | $28M | $33M | $-8M | $-6M | $-3M | $2M | $3M | $3M | $7M | $13M | $18M | $24M | $31M | $37M | $42M | $48M | |
| Liabilities + Equity | $52M | $59M | $10M | $17M | $24M | $37M | $44M | $44M | $54M | $58M | $70M | $84M | $96M | $108M | $108M | $104M |
Flujo de Efectivo 10
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $161.0K | $186.0K | $223.0K | $240.0K | $251.0K | $266.0K | $259.0K | $255.0K | $248.0K | $227.0K | $218.0K | $189.0K | $188.0K | $174.0K | $141.0K | $122.0K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | $4M | |
| Operating Cash Flow | $-6M | $294.0K | $-5M | $-6M | $-8M | $-9M | $-8M | $-9M | $-9M | $-12M | $-14M | $-12M | $-12M | $-15M | $-12M | $-10M | |
| CapEx | $15.0K | $0 | $0 | $37.0K | $51.0K | $31.0K | $125.0K | $94.0K | $18.0K | $167.0K | $479.0K | $335.0K | $248.0K | $530.0K | $456.0K | $379.0K | |
| Investing Cash Flow | $-2M | $-31M | $0 | $6M | $18M | $3M | $469.0K | $7M | $10M | $13M | $12M | $789.0K | $4M | $-457.0K | $-71M | $-379.0K | |
| Net Debt Issued | $0 | · | · | · | $-4M | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | $-27.0K | $45M | $-1M | $188.0K | $-4M | $6M | $8M | $141.0K | $121.0K | $96.0K | $49.0K | $80.0K | $8.0K | $15M | $14M | $49.0K | |
| Net Change in Cash | $-9M | $14M | $-6M | $105.0K | $6M | $-515.0K | $-237.0K | $-2M | $1M | $892.0K | $-3M | $-11M | $-8M | $-212.0K | $-69M | $-11M | |
| Free Cash Flow | $-7M | · | · | · | $-8M | · | · | · | $-9M | · | · | · | $-12M | · | · | · |
Rentabilidad 6
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -488.2% | · | · | · | -6984.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -411.8% | · | · | · | -4223.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -488.2% | · | · | · | -6984.3% | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -18.5% | · | -20.2% | -22.1% | -18.7% | · | -11.9% | -10.7% | -10.0% | · | -10.3% | -9.9% | -7.9% | · | -6.5% | -8.4% | |
| ROE | -55.5% | · | 228.4% | 488.5% | -334.6% | · | -65.6% | -50.5% | -39.3% | · | -30.8% | -25.9% | -19.9% | · | -17.0% | -31.9% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | -38.1% | -34.3% | · | · | -28.8% | -33.5% |
Liquidez y Solvencia 5
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | · | 0.3 | 0.5 | 0.9 | · | 1.6 | 1.9 | 3.1 | · | 8.6 | 13.3 | 17.3 | · | 14.0 | 18.3 | |
| Quick Ratio | 0.8 | · | 0.2 | 0.5 | 0.5 | · | 0.2 | 0.3 | 0.5 | · | 0.7 | 1.3 | 3.7 | · | 3.8 | 18.2 | |
| Debt / Equity | · | · | -1.7 | -3.1 | -6.8 | · | 9.1 | 10.4 | 4.0 | · | 1.7 | 1.2 | 1.0 | · | 0.3 | · | |
| LT Debt / Equity | · | · | 0.0 | -0.4 | -1.9 | · | 4.3 | 6.1 | 2.8 | · | 1.6 | 1.2 | 1.0 | · | 0.3 | · | |
| Interest Coverage | -94.8 | · | -10.0 | -12.0 | -12.7 | · | -8.8 | -9.8 | -10.8 | · | -13.6 | -14.5 | -13.7 | · | -46.4 | · |
Eficiencia 2
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | |
| Receivables Turnover | 1.3 | · | · | · | 0.6 | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 4
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | · | $172.0K | $172.0K | $172.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | $-26M | · | $-26M | $-28M | $-28M | · | $-30M | $-33M | $-34M | · | $-35M | $-33M | $-30M | · | $-25M | · | |
| P/E | -1.3 | · | -0.7 | -0.6 | -1.2 | · | -1.9 | -3.0 | -2.3 | · | -3.0 | -68.7 | 8.6 | · | 12.4 | · | |
| Earnings Yield | -76.2% | · | -152.0% | -175.1% | -80.2% | · | -53.2% | -33.7% | -43.4% | · | -33.6% | -1.5% | 11.6% | · | 8.0% | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $2M | $1M | $0 | $0 | $3M |
| Margen Operativo % | -2346.0% | -5186.2% | — | — | -1899.1% |
| Beneficio neto | $-30M | $-30M | $-34M | $-31M | $-8M |
| EPS Diluido | $-0.45 | $-1.05 | $-1.33 | $-1.28 | $-0.43 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.0 | 12.4 | 2.3 | 0.8 | — |
| Ratio corriente | 4.2 | 1.5 | 6.4 | 21.0 | 45.3 |
| Ratio Rápido | 1.6 | 0.2 | 0.7 | 26.1 | 44.5 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-19M | $-36M | $-52M | $-48M | $-33M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.